NCT02735434

Brief Summary

Health anxiety is a prevalent, disabling disorder associated with extensive health care expenditures. The lack of easily accessible, evidence-based psychological treatment combined with delayed diagnostic recognition constitute barriers to receiving treatment. Aim

  1. 1.To develop an internet-delivered treatment program, based on 'Acceptance and Commitment Therapy' (ACT), for patients with health anxiety.
  2. 2.To test the feasibility and effectiveness of the treatment programme in a randomized, controlled trial, comparing the treatment with an active control condition.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2016

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 1, 2016

Completed
Same day until next milestone

Study Start

First participant enrolled

April 1, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 12, 2016

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
Last Updated

April 30, 2021

Status Verified

March 1, 2017

Enrollment Period

1 year

First QC Date

April 1, 2016

Last Update Submit

April 27, 2021

Conditions

Keywords

Health anxietyillness anxiety disorderACTinternet

Outcome Measures

Primary Outcomes (1)

  • Whiteley-7 index

    Health anxiety symptoms

    At baseline (i.e. at self-referral), before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline) and 1, 2, 3 and 9 months after randomisation

Secondary Outcomes (9)

  • Demographic questions measured with questions from the Danish study for Functional Disorders (DanFund)

    At baseline (i.e. at self-referral)

  • Diagnosed somatic illnesses measured with questions from the Danish study for Functional Disorders (DanFund)

    At baseline (i.e. at self-referral)

  • Quality of life measured with the World Health Organisation Well-being Index-Five (WHO-5)

    At baseline (i.e. at self-referral), before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline) and 1, 2, 3 and 9 months after randomisation

  • Quality of life measured with the visual analogue scale (VAS question) from Youth profile, National Institute of Public Health

    At baseline (i.e. at self-referral), before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline) and 1, 2, 3 and 9 months after randomisation

  • Stress measured with questions from the survey Youth stress, Danish Health Authority

    At baseline (i.e. at self-referral), before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline) and 1, 2, 3 and 9 months after randomisation

  • +4 more secondary outcomes

Other Outcomes (16)

  • Psychological flexibility measured with the Acceptance and Action Questionnaire-II (AAQ-II)

    At baseline (i.e. at self-referral), and 1, 2, 3 and 9 months after randomisation

  • Non-reactivity measured with a subscale of the Five Facet Mindfulness Questionnaire (FFMQ)

    At baseline (i.e. at self-referral), and 1, 2, 3 and 9 months after randomisation

  • Illness perception measured with the Brief Illness Perception Questionnaire (B-IPQ)

    At baseline (i.e. at self-referral), and 1, 2, 3 and 9 months after randomisation

  • +13 more other outcomes

Study Arms (2)

Internet-based ACT

EXPERIMENTAL

Brief clinical psychiatric assessment to determine eligibility (video-based).

Behavioral: Internet-based ACT

Internet-based discussion forum

ACTIVE COMPARATOR

Brief clinical psychiatric assessment to determine eligibility (video-based).

Other: Internet-based discussion forum

Interventions

The guided internet program consists of 7 modules activated consecutively over a period of 12 weeks. The content is written psycho education, patient videos, audio-exercises and behavioural exposure exercises. The program is therapist-guided; hence all patients will receive support from primarily the same therapist during the 12 weeks.

Internet-based ACT

The online discussion forum consists of 7 themes touching upon the impact of health anxiety and the patients own coping strategies. The themes are activated consecutively over a period of 12 weeks. The discussion forum is text-based, and only patients will participate in the discussion. The written discussions will be reviewed by a professional for ethical reasons. The discussion forum aims to control for the effect of attention and contacts to the health care system. After 9 months patients in the discussion forum are offered active treatment, but not as part of the research project.

Internet-based discussion forum

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Severe health anxiety \> 6 months
  • Whiteley-7 score (scale 0-100 score points) corresponding to 21,4 or more.
  • Age above 18 years old
  • In case of a comorbid functional or other psychiatric disorder health anxiety must be the dominant problem
  • Patients who speak, read and write Danish
  • Access to a computer and internet access
  • Residence in Denmark

You may not qualify if:

  • Acute suicidal risk
  • Abuse of narcotics or alcohol and (non-prescribed) medicine
  • Lifetime-diagnosis of psychoses, bipolar affective disorder or depression with psychotic symptoms (ICD-10: F20-29, F30-31, F32.3, F33.3)
  • Pregnancy
  • Unstable psychopharmacological treatment within last 2 months
  • Former treatment at the Research Clinic for Functional Disorders and Psychosomatics
  • Not providing informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Risor BW, Frydendal DH, Villemoes MK, Nielsen CP, Rask CU, Frostholm L. Cost Effectiveness of Internet-Delivered Acceptance and Commitment Therapy for Patients with Severe Health Anxiety: A Randomised Controlled Trial. Pharmacoecon Open. 2022 Mar;6(2):179-192. doi: 10.1007/s41669-021-00319-x. Epub 2022 Jan 8.

  • Hoffmann D, Rask CU, Hedman-Lagerlof E, Jensen JS, Frostholm L. Efficacy of internet-delivered acceptance and commitment therapy for severe health anxiety: results from a randomized, controlled trial. Psychol Med. 2021 Nov;51(15):2685-2695. doi: 10.1017/S0033291720001312. Epub 2020 May 14.

  • Hoffmann D, Rask CU, Hedman-Lagerlof E, Eilenberg T, Frostholm L. Accuracy of self-referral in health anxiety: comparison of patients self-referring to internet-delivered treatment versus patients clinician-referred to face-to-face treatment. BJPsych Open. 2019 Sep 9;5(5):e80. doi: 10.1192/bjo.2019.54.

Related Links

MeSH Terms

Conditions

Hypochondriasis

Condition Hierarchy (Ancestors)

Somatoform DisordersMental Disorders

Study Officials

  • Lisbeth Frostholm, PhD

    Aarhus University Hospital

    PRINCIPAL INVESTIGATOR
  • Charlotte U Rask, PhD

    Aarhus University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2016

First Posted

April 12, 2016

Study Start

April 1, 2016

Primary Completion

April 1, 2017

Study Completion

March 1, 2018

Last Updated

April 30, 2021

Record last verified: 2017-03